Structure and Interactions of Conformational Intermediates in gamma-D Crystallin Aggregation, and Their Targeting for Cataract Prevention
γ-D 晶状体蛋白聚集中构象中间体的结构和相互作用及其预防白内障的靶向作用
基本信息
- 批准号:10401812
- 负责人:
- 金额:$ 40.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAgeAge of OnsetAgingAmericanBiochemicalBiochemistryBiologicalBiological AssayBlindnessC-terminalCatalysisCataractChemicalsChemistryCollaborationsComputing MethodologiesCoupledCrystalline LensCrystallinsDNA Sequence AlterationDataDevelopmentDiseaseDisulfidesEvolutionEye SurgeonFDA approvedFutureGeneticHomoHumanIn VitroKineticsKnowledgeLeadLinkMapsMass Spectrum AnalysisMeasuresMedicalMethodsModelingModificationMolecular ConformationMonte Carlo MethodMutationN-terminalOperative Surgical ProceduresOxidation-ReductionOxidoreductasePathway interactionsPatientsPeptidesPharmaceutical PreparationsPhysical ChemistryPhysiologicalPopulationPost-Translational Protein ProcessingPreventionPrionsProcessPropertyProtein EngineeringProteinsProteolysisProteomicsResearchSavingsSeveritiesSiteSourceStructural ModelsStructureTemperatureTestingTheftTherapeuticThermodynamicsTimeTissuesUnited States National Institutes of HealthVariantVisual impairmentWorkagedanalytical ultracentrifugationbasecongenital cataractcostcrosslinkdeamidationdesigndisulfide bondgamma-Crystallinshydrophilicityimprovedin silicoin vitro testingin vivoinhibitorkinetic modelknowledge baselenslight scatteringmathematical modelmouse modelmutantnon-Nativenoveloxidationpeptidomimeticspolypeptidepreventprion-likeprotein aggregationprotein protein interactionprotein structurerational designresidencesimulationsolid state nuclear magnetic resonancesynergism
项目摘要
PROJECT ABSTRACT
Cataracts result from progressive aggregation of eye lens crystallin proteins. Severity of age-onset cataract has
been linked to specific post-translational modifications in crystallins that accumulate during aging. Two important
classes of cataract-associated modifications are oxidation of Trp residues to more hydrophilic products and
oxidation of Cys residues to generate disulfide bonds. Our prior research has revealed a crucial synergy between
the two. The W42Q variant of human γD crystallin (a Trp oxidation mimic) and the W42R congenital-cataract
variant, are destabilized but well folded and soluble under reducing conditions, yet formation of a non-native
internal disulfide bond (Cys32-Cys41) kinetically traps them in a partially unfolded conformational intermediate,
generating rapid and robust aggregation at physiologically relevant temperature, pH, and concentration in vitro.
We have developed a rapid, atomistic Monte-Carlo modeling method, with a knowledge-based statistical
potential, that is uniquely suited for the study of conformational intermediates, including in multiple polypeptide
chains as they simultaneously unfold to reveal new protein-protein interactions. We have already applied this
method to γD crystallin and its variants to predict not only the structure of the aggregation-prone intermediate
but also, for the first time, an atomistic model of the aggregated state. Experimentally, we recently discovered a
novel oxidoreductase activity in human γD crystallin and demonstrated that native-state disulfides in WT can be
transferred to generate the non-native, aggregation-promoting disulfide in W42Q. We found an even more
surprising WT/mutant interaction – domain interface stealing – that allows WT to catalyze mutants’ aggregation
even in the presence of an abundant external disulfide source. We will now (1) investigate the physical principles,
kinetics, and evolutionary and disease implications of the novel interface stealing interaction by a combined
computational, biochemical, and proteolysis/mass spectrometry approach we are now developing; and (2)
distinguish among atomistic models for the aggregation precursor and the aggregated state and (3) apply these
newly refined atomistic models to rationally design structure-based peptide inhibitors of the aggregation process.
Although our studies have focused on the W42Q/R variants, other cataract-associated variants (V75D, L5S)
appear to behave quite similarly. Moreover, both the native and the non-native disulfide we identified as culprits
in aggregation processes have been entirely supported by tissue proteomics of aged and cataractous human
lenses in the absence of any genetic mutation. We will therefore test the hypothesis that many mutations or post-
translational modifications converge on few conformational intermediates that determine aggregation. We will
generalize the detailed mechanistic and structural picture of aggregation to other γ-crystallins and other cataract-
associated variants testing whether human γC and γS crystallins are also redox-active and capable of interface
stealing. A more general understanding of the synergy between structural destabilization and redox chemistry in
cataract will improve design of aggregation inhibitors testable on existing genetic mouse models of cataract.
项目摘要
白内障是由眼透镜晶体蛋白的进行性聚集引起的。老年性白内障的严重程度
与老化过程中积累的晶状体蛋白中的特定翻译后修饰有关。两个重要
与白内障相关的修饰类型是Trp残基氧化成更亲水的产物,
Cys残基氧化产生二硫键。我们之前的研究揭示了一个关键的协同作用,
the two.人γD晶状体蛋白的W 42 Q变体(Trp氧化模拟物)和W 42 R先天性白内障
变体,是不稳定的,但在还原条件下良好折叠和可溶,但形成非天然的
内部二硫键(Cys 32-Cys 41)将它们动力学地捕获在部分未折叠的构象中间体中,
在体外生理相关温度、pH和浓度下产生快速和稳健的聚集。
我们已经开发了一种快速的原子蒙特-卡罗建模方法,
潜在的,这是唯一适合于构象中间体的研究,包括在多个多肽
它们同时展开以揭示新的蛋白质-蛋白质相互作用。我们已经应用了这个
γD晶状体蛋白及其变体的方法不仅可以预测易于聚集的中间体的结构
而且,第一次,一个原子模型的聚合状态。通过实验,我们最近发现了一种
在人γD晶状体蛋白中具有新的氧化还原酶活性,并证明WT中的天然状态二硫化物可以
转移以在W 42 Q中产生非天然的促进聚集的二硫化物。我们发现了一个
令人惊讶的WT/突变体相互作用-结构域界面窃取-允许WT催化突变体的聚集
即使在存在大量外部二硫化物源的情况下。我们现在将(1)研究物理原理,
动力学,进化和疾病的影响,新的接口窃取相互作用的组合
我们正在开发的计算、生物化学和蛋白质水解/质谱分析方法;以及(2)
区分聚集前体和聚集状态的原子模型,以及(3)应用这些模型
新改进的原子模型,以合理设计基于结构的肽抑制剂的聚集过程。
虽然我们的研究集中在W 42 Q/R变异,但其他白内障相关变异(V75 D,L5 S)
表现得很相似此外,我们确定天然和非天然二硫化物都是罪魁祸首。
在聚集过程中,老年人和白内障患者的组织蛋白质组学完全支持
在没有任何基因突变的情况下。因此,我们将测试假设,许多突变或后-
翻译修饰集中在少数决定聚集的构象中间体上。我们将
将聚集的详细机制和结构图片推广到其他γ-晶体蛋白和其他白内障-
相关变体测试人γC和γS晶体蛋白是否也具有氧化还原活性并能够介导
偷东西更一般的理解之间的协同作用的结构不稳定和氧化还原化学,
白内障将改进可在现有的白内障遗传小鼠模型上测试的聚集抑制剂的设计。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EUGENE I SHAKHNOVICH其他文献
EUGENE I SHAKHNOVICH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EUGENE I SHAKHNOVICH', 18)}}的其他基金
Biophysical foundations of evolutionary dynamics
进化动力学的生物物理学基础
- 批准号:
10633124 - 财政年份:2021
- 资助金额:
$ 40.39万 - 项目类别:
Biophysical foundations of evolutionary dynamics
进化动力学的生物物理学基础
- 批准号:
10452241 - 财政年份:2021
- 资助金额:
$ 40.39万 - 项目类别:
Biophysical foundations of evolutionary dynamics
进化动力学的生物物理基础
- 批准号:
10413808 - 财政年份:2021
- 资助金额:
$ 40.39万 - 项目类别:
Structure and Interactions of Conformational Intermediates in gamma-D Crystallin Aggregation, and Their Targeting for Cataract Prevention
γ-D 晶状体蛋白聚集中构象中间体的结构和相互作用及其预防白内障的靶向作用
- 批准号:
10608130 - 财政年份:2020
- 资助金额:
$ 40.39万 - 项目类别:
Study of phenotypic and fitness effects of non-functional protein interactions in
非功能性蛋白质相互作用的表型和适应度效应研究
- 批准号:
8912519 - 财政年份:2014
- 资助金额:
$ 40.39万 - 项目类别:
Study of Biological Evolution of Structure and Function in Proteins
蛋白质结构和功能的生物进化研究
- 批准号:
8624697 - 财政年份:2004
- 资助金额:
$ 40.39万 - 项目类别:
Evolutionary study of structure-function relationship
结构-功能关系的进化研究
- 批准号:
6773025 - 财政年份:2004
- 资助金额:
$ 40.39万 - 项目类别:
Realistic protein folding with hydrophobic potentials
具有疏水潜力的真实蛋白质折叠
- 批准号:
6844886 - 财政年份:2004
- 资助金额:
$ 40.39万 - 项目类别:
Evolutionary study of structure-function relationship
结构-功能关系的进化研究
- 批准号:
6874497 - 财政年份:2004
- 资助金额:
$ 40.39万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 40.39万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 40.39万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 40.39万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 40.39万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 40.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 40.39万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 40.39万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 40.39万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 40.39万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 40.39万 - 项目类别:
Miscellaneous Programs